{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-031668","form_type":"8-K","ticker":"CING","cik":"0001862150","company_name":"Cingulate Inc.","filed_at":"2026-07-02T12:40:16+00:00","discovered_at":"2026-07-02T12:45:00.833224+00:00","generated_at":"2026-07-02T12:45:14.920582+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Cingulate joins Russell 3000E Index; CMO trial period extended to Sept 30","bullets":["Added to Russell 3000E Index, effective after June 2026 reconstitution; semi-annual reconstitution begins Dec 2026.","CEO Shane Schaffer says inclusion enhances visibility with institutional investors and supports long-term growth.","Employment agreement amendment extends CMO Matthew N. Brams' trial period from June 30 to September 30, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-031668","json":"https://secwatch.observer/filing/0001493152-26-031668.json","markdown":"https://secwatch.observer/filing/0001493152-26-031668.md","text":"https://secwatch.observer/filing/0001493152-26-031668.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1862150/000149315226031668/0001493152-26-031668-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1862150/000149315226031668/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-02T12:45:14.920582+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}